Phase II trial of 4′-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer

Ted Braich, Frederick R. Ahmann, Harinder S. Garewal, Aurelia Robertone, Sydney E. Salmon

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 4′-deoxydoxorubicin (esorubicin) in hormone resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences